Publications for Alison A. McCormick alison.mccormick@tu.edu
Zhou, Y., McCormick, A. A., & Kearney, C. M. (2017). Plant expression of trans-encapsidated viral nanoparticle vaccines with animal RNA replicons. RNA Vaccines, 1499, 77-86. doi:10.1007/978-1-4939-6481-9_4
Arnaboldi, P. M., Sambir, M., D'Arco, C., Peters, L. A., Seegers, J. F., Mayer, L., McCormick, A. A., & Dattwyler, R. J. (2016). Intranasal delivery of a protein subunit vaccine using a tobacco mosaic virus platform protects against pneumonic plague. Vaccine, 34(47), 5768-5776. doi:10.1016/j.vaccine.2016.09.063
Mallajosyula, J. K., Jeevan, T., Chikwamba, R., Webby, R. J., & McCormick, A. A. (2016). A single dose TMV-HA vaccine protects mice from H5N1 influenza challenge. International Journal of Vaccine Research, 1(2) [Article 6]. This material can be found here.
Banik, S., Mansour, A. A., Suresh, R. V., Wykoff-Clary, S., Malik, M., McCormick, A. A., & Bakshi, C. S. (2015). Development of a multivalent subunit vaccine against tularemia using tobacco mosaic virus (TMV) based delivery system. PLoS One, 10(6) [Article e0130858]. doi:10.1371/journal.pone.0130858
Zhou, Y., Maharaj, P., Mallajosyula, J., McCormick, A., & Kearney, C. (2015). In planta production of flock house virus transencapsidated RNA and its potential use as a vaccine. Molecular Biotechnology, 57(4), 325-336. doi:10.1007/s12033-014-9826-1
Barton, C., Kouokam, J. C., Lasnik, A. B., Foreman, O., . . . McCormick, A. A., O'Keefe, B. R., & Palmer, K. E. (2014). Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models. Antimicrobial Agents and Chemotherapy, 58(1), 120-127. doi:10.1128/AAC.01407-13
Kemnade, J. O., Seethammagaria, M., Collinson-Pautza, M., Kaur, H., Spencer, D. M., & McCormick, A. A. (2014). Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivo. Vaccine, 32(33), 4228-4233. doi:10.1016/j.vaccine.2014.04.051
Maharaj, P. D., Mallajosyula, J. K., Lee, G., Thi, P., Zhou, Y., Kearney, C. M., & McCormick, A. A. (2014). Nanoparticle encapsidation of flock house virus by auto assembly of tobacco mosaic virus coat protein. International Journal of Molecular Sciences, 15(10), 18540-18556. doi:10.3390/ijms151018540
Maharaj, P. D., Mallajosyula, J. K., Thi, P., Lee, G., Zhou, Y., Kearney, C., & McCormick, A. A. (2014). Trans-encapsidation of flock house virus with tobacco mosaic virus structural proteins. Journal of Advanced Biotechnology and Bioengineering, 2, 49-59. doi:10.12970/2311-1755.2014.02.02.2
Mallajosyula, J. K., Hiatt, E., Hume, S., Johnson, A., Jeevan, T., Chicwamba, R., . . . McCormick, A. A. (2014). Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge. Human Vaccines and Immunotherapy, 10(3), 586-595. doi:10.4161/hv.27567
Kemnade, J. O., Seethammagari, M., Narayanan, P., Levitt, J. M., McCormick, A. A., & Spencer, D. M. (2012). Off-the-shelf adenoviral-mediated immunotherapy via bicistronic expression of tumor antigen and iMyD88/CD40 adjuvant. Molecular Therapy, 20(7), 1462-1471. doi:10.1038/mt.2012.48
McCormick, A. A., Jacobsen, I.D., Broniszewska, M., Beck, J., Heesemann, J., & Ebel, F. (2012). The two-component sensor kinase TcsC and its role in stress resistance of the human-pathogenic mold aspergillus fumigatus, PLoS One, 7(6) [Article 38262]. doi:10.1371/journal.pone.0038262
Bouzani, M., Ok, M., McCormick, A. A., Ebel, F., Kurzai, O., Morton, C.O.,. . . Loeffler, J. (2011). Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-γ release. Journal of Immunology, 187(3), 1369-1376. doi:10.4049/jimmunol.1003593
McCormick, A. A. (2011). Tobacco-derived cancer vaccines for non-Hodgkin's lymphoma: Perspectives and progress. Human Vaccine, 7(3), 305-312.
Bendandi, M., Marillonnet, S., Kandzia, R., Thieme, F., Nickstadt, A., McCormick, A. A., . . . Gleba, Y. (2010). Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Annals of Oncology Online, 21(12), 2420-2427. doi:10.1093/annonc/mdq256
McCormick, A. A., Heesemann, L., Wagener, J., Marcos, V., Hartl, D., Loeffler, J., . . . Ebel, F. (2010). NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. Microbes and Infection, 12(12-13), 928-936. doi:10.1016/j.micinf.2010.06.009
McCormick, A. A., Loeffler, J., & Ebel, F. (2010). Aspergillus fumigatus: Contours of an opportunistic human pathogen. Cellular Microbiology, 12(11), 1535-1543. doi:10.1111/j.1462-5822.2010.01517.x
McCormick, A. A., & Palmer, K. E. (2008). Genetically engineered tobacco mosaic virus as nanoparticle vaccines. Expert Review of Vaccines 7(1), 33-41. doi:10.1586/14760584.7.1.33
McCormick, A. A., Reddy, S., Reinl, S. J., Cameron, T. I., Czerwinkski, D. K., Vojdani, F., . . . Levy, R. (2008). Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: Safety and immunogenicity in a phase I clinical study. Proceedings of the National Academy of Sciences of the United States of America, 105(29), 10131-10136. doi:10.1073/pnas.0803636105
Smith, M. L., Corbo, T., Bernales, J., Lindbo, J. A., Pogue, G. P., Palmer, K. E., & McCormick, A. A. (2007). Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens. Virology, 358(2), 321-333. doi:10.1016/j.virol.2006.08.040
McCormick, A. A., Corbo, T. A., Wykoff-Clary, S., Nguyen, L. V., Smith, M. L., Palmer, K. E., & Pogue, G. P. (2006). TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models. Vaccine, 24(40-41), 6414-6423. doi:10.1016/j.vaccine.2006.06.003
McCormick, A. A., Corbo, T. A., Wykoff-Clary, S., Palmer, K. E., & Pogue, G. P. (2006). Chemical conjugate TMV-peptide bivalent fusion vaccines improve cellular immunity and tumor protection. Bioconjugate Chemistry, 17(5), 1330-1338. doi:10.1021/bc060124m
Palmer, K. E., Benko, A., Doucette, S. A., Cameron, T. I., Foster, T., Hanley, K. M., . . . McCormick, A. A. (2006). Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes. Vaccine, 24(26), 5516-5525. doi:10.1016/j.vaccine.2006.04.058
Smith, M. L., Lindbo, J. A., Dillard-Telm, S., Brosio, P. M., Lasnik, A. B., McCormick, A. A., . . . Nguyen, L. V. (2006). Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications. Virology, 348(2), 475-488. doi:10.1016/j.virol.2005.12.039
McCormick, A. A., Reinl, S. J., Cameron, T. I., Vojdani, F., Fronefield, M., Levy, R., & Tusé, D. (2003). Individualized human scFv vaccines produced in plants: Humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig. Journal of Immunological Methods, 278(1-2), 95-104. doi:10.1016/S0022-1759(03)00208-4
